Affimed NV
OTC:AFMDQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Affimed NV
OTC:AFMDQ
|
DE |
|
Access Intelligence PLC
LSE:ACC
|
UK |
|
Hypothekarbank Lenzburg AG
SIX:HBLN
|
CH |
|
C
|
Canada Energy Partners Inc
XTSX:CE.H
|
CA |
|
Duksung Co Ltd
KRX:004830
|
KR |
|
Ifnw Dissolution Corp
OTC:INOW
|
US |
|
Lai Si Enterprise Holding Ltd
HKEX:2266
|
MO |
|
Z
|
Zur Rose Group AG
SIX:ROSE
|
CH |
|
E
|
Elife Holdings Ltd
F:K4I
|
HK |
|
F
|
Figene Capital SA
WSE:FIG
|
PL |
|
Fritz Nols AG
F:FNG
|
DE |
|
Braskem SA
BOVESPA:BRKM5
|
BR |
|
P
|
Pilkington Deutschland AG
XHAM:FDD
|
DE |
|
B
|
Bich Chi Food Co
VN:BCF
|
VN |
|
R
|
RBC Bioscience Corp
TPEX:6848
|
TW |
|
HMS Hydraulic Machines & Systems Group PLC
LSE:HMSG
|
RU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AFMDQ's stock price target?
Not Available
AFMDQ does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Affimed NV?
Projected CAGR
14%
Over the last 10 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 4 years is 14%.